Related Experiment Video

Updated: May 15, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

Heather A Hirsch1, Dimitrios Iliopoulos, Kevin Struhl

  • 1Department Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Proceedings of the National Academy of Sciences of the United States of America
|January 2, 2013
PubMed

Insights

Metformin, a diabetes drug, inhibits cancer stem cell transformation by blocking the inflammatory pathway NF-κB. This anti-cancer effect is linked to altered cellular metabolism and shows promise in combination therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Research

Background:

  • Metformin is a widely used diabetes medication.
  • Cancer stem cells (CSCs) are crucial for tumor growth and metastasis.
  • Inflammation plays a significant role in cancer development.

Purpose of the Study:

  • To investigate metformin's effect on cellular transformation and CSCs.
  • To elucidate the molecular mechanisms underlying metformin's anti-cancer activity.
  • To evaluate metformin's potential in combination cancer therapy.

Main Methods:

  • Utilized Src-inducible models for cellular transformation studies.
  • Assessed the impact of metformin on NF-κB and STAT3 signaling pathways.
  • Conducted xenograft studies in mice using various cancer cell lines.
  • Investigated the role of downstream NF-κB targets like Lin28B and IL1β.

Main Results:

  • Metformin inhibited early cellular transformation by blocking NF-κB activation.
  • Metformin preferentially targeted CSCs by inhibiting NF-κB and STAT3.
  • Metformin combined with doxorubicin prolonged remission in xenografts.
  • Therapeutic efficacy was observed in inflammatory cancer models but not non-inflammatory ones.

Conclusions:

  • Metformin inhibits a critical inflammatory pathway involved in cancer.
  • Metformin's anti-cancer effects may stem from its influence on cellular metabolism.
  • Metformin-based combination therapy holds potential for treating inflammatory cancers.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...